| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.72B | +3.1% |
| Cost of Revenue | $1.09B | +1.0% |
| R&D Expense | $20.9M | +2.0% |
| Operating Income | $118.4M | -28.1% |
| Interest Expense | $19.4M | -20.2% |
| Pre-tax Income | $95.3M | -37.8% |
| Income Tax | $10.7M | -54.5% |
| Net Income | $85.4M | -85.3% |
| EPS (Basic) | $2.67 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.23B | +154.2% |
| Accounts Receivable | $239.7M | +11.8% |
| Inventory | $233.1M | -2.4% |
| Current Assets | $1.86B | +69.4% |
| Total Assets | $3.41B | +26.0% |
| Current Liabilities | $535.5M | +10.5% |
| Long-term Debt | $1.25B | +93.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Financing Cash Flow | $561.8M | +258.7% |
| -85.3% |
| EPS (Diluted) | $2.65 | -85.4% |
| Stockholders' Equity |
| $1.54B |
| +3.7% |